Characterization of zanubrutinib safety and tolerability profile and comparison with ibrutinib safety profile in patients with B-cell malignancies: post hoc analysis of a large clinical trial safety database

Brown, J. R., Ghia, P., Jurczak, W., Kahl, B. S., Lamanna, N., Robak, T., Shadman, M., Tam, C. S., Qiu, L., Paik, J., Salmi, T., Wang, L., Zhang, J., Zhang, M., Cohen, A., Ma, H., & Tedeschi, A. (2024). Characterization of zanubrutinib safety and tolerability profile and comparison with ibrutinib safety profile in patients with B-cell malignancies: post hoc analysis of a large clinical trial safety database. Haematologica. https://doi.org/10.3324/haematol.2023.283846
Authors:
Jennifer R. Brown
Paolo Ghia
Wojciech Jurczak
Brad S. Kahl
Nicole Lamanna
Tadeusz Robak
Mazyar Shadman
Constantine S. Tam
Lugui Qiu
Jason C. Paik
Tommi Salmi
Liping Wang
Jun Zhang
Meng Zhang
Aileen Cohen
Hong Zhang
Alessandra Tedeschi
Affiliated Authors:
Nicole Lamanna
Publication Type:
Article
Unique ID:
10.3324/haematol.2023.283846
PMID:
Journal:
Publication Date:
Data Source:
OpenAlex

Record Created: